329 related articles for article (PubMed ID: 33802229)
1. iPSC-Cardiomyocyte Models of Brugada Syndrome-Achievements, Challenges and Future Perspectives.
Nijak A; Saenen J; Labro AJ; Schepers D; Loeys BL; Alaerts M
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802229
[TBL] [Abstract][Full Text] [Related]
2. Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.
Liang P; Sallam K; Wu H; Li Y; Itzhaki I; Garg P; Zhang Y; Vermglinchan V; Lan F; Gu M; Gong T; Zhuge Y; He C; Ebert AD; Sanchez-Freire V; Churko J; Hu S; Sharma A; Lam CK; Scheinman MM; Bers DM; Wu JC
J Am Coll Cardiol; 2016 Nov; 68(19):2086-2096. PubMed ID: 27810048
[TBL] [Abstract][Full Text] [Related]
3. hiPSC-derived cardiomyocytes from Brugada Syndrome patients without identified mutations do not exhibit clear cellular electrophysiological abnormalities.
Veerman CC; Mengarelli I; Guan K; Stauske M; Barc J; Tan HL; Wilde AA; Verkerk AO; Bezzina CR
Sci Rep; 2016 Aug; 6():30967. PubMed ID: 27485484
[TBL] [Abstract][Full Text] [Related]
4. Patient-specific iPSC-derived cardiomyocytes reveal variable phenotypic severity of Brugada syndrome.
Sun Y; Su J; Wang X; Wang J; Guo F; Qiu H; Fan H; Cai D; Wang H; Lin M; Wang W; Feng Y; Fu G; Gong T; Liang P; Jiang C
EBioMedicine; 2023 Sep; 95():104741. PubMed ID: 37544203
[TBL] [Abstract][Full Text] [Related]
5. Sodium channel current loss of function in induced pluripotent stem cell-derived cardiomyocytes from a Brugada syndrome patient.
Selga E; Sendfeld F; Martinez-Moreno R; Medine CN; Tura-Ceide O; Wilmut SI; Pérez GJ; Scornik FS; Brugada R; Mills NL
J Mol Cell Cardiol; 2018 Jan; 114():10-19. PubMed ID: 29024690
[TBL] [Abstract][Full Text] [Related]
6. A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes.
El-Battrawy I; Albers S; Cyganek L; Zhao Z; Lan H; Li X; Xu Q; Kleinsorge M; Huang M; Liao Z; Zhong R; Rudic B; Müller J; Dinkel H; Lang S; Diecke S; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou X; Akin I
Europace; 2019 Sep; 21(9):1410-1421. PubMed ID: 31106349
[TBL] [Abstract][Full Text] [Related]
7. Patient-specific iPSC-derived cardiomyocytes reveal aberrant activation of Wnt/β-catenin signaling in SCN5A-related Brugada syndrome.
Cai D; Wang X; Sun Y; Fan H; Zhou J; Yang Z; Qiu H; Wang J; Su J; Gong T; Jiang C; Liang P
Stem Cell Res Ther; 2023 Sep; 14(1):241. PubMed ID: 37679791
[TBL] [Abstract][Full Text] [Related]
8. A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells.
Zhong R; Schimanski T; Zhang F; Lan H; Hohn A; Xu Q; Huang M; Liao Z; Qiao L; Yang Z; Li Y; Zhao Z; Li X; Rose L; Albers S; Maywald L; Müller J; Dinkel H; Saguner A; Janssen JWG; Swamy N; Xi Y; Lang S; Kleinsorge M; Duru F; Zhou X; Diecke S; Cyganek L; Akin I; El-Battrawy I
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955449
[TBL] [Abstract][Full Text] [Related]
9. Disrupted Ca
Kashiwa A; Makiyama T; Kohjitani H; Maurissen TL; Ishikawa T; Yamamoto Y; Wuriyanghai Y; Gao J; Huang H; Imamura T; Aizawa T; Nishikawa M; Chonabayashi K; Mishima H; Ohno S; Toyoda F; Sato S; Yoshiura KI; Takahashi K; Yoshida Y; Woltjen K; Horie M; Makita N; Kimura T
Heart Rhythm; 2023 Jan; 20(1):89-99. PubMed ID: 36007726
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Wnt/β-catenin signaling upregulates Na
Lu A; Gu R; Chu C; Xia Y; Wang J; Davis DR; Liang W
Physiol Rep; 2023 May; 11(10):e15696. PubMed ID: 37226398
[TBL] [Abstract][Full Text] [Related]
11. RRAD mutation causes electrical and cytoskeletal defects in cardiomyocytes derived from a familial case of Brugada syndrome.
Belbachir N; Portero V; Al Sayed ZR; Gourraud JB; Dilasser F; Jesel L; Guo H; Wu H; Gaborit N; Guilluy C; Girardeau A; Bonnaud S; Simonet F; Karakachoff M; Pattier S; Scott C; Burel S; Marionneau C; Chariau C; Gaignerie A; David L; Genin E; Deleuze JF; Dina C; Sauzeau V; Loirand G; Baró I; Schott JJ; Probst V; Wu JC; Redon R; Charpentier F; Le Scouarnec S
Eur Heart J; 2019 Oct; 40(37):3081-3094. PubMed ID: 31114854
[TBL] [Abstract][Full Text] [Related]
12. Brugada Syndrome: Different Experimental Models and the Role of Human Cardiomyocytes From Induced Pluripotent Stem Cells.
Li Y; Lang S; Akin I; Zhou X; El-Battrawy I
J Am Heart Assoc; 2022 Apr; 11(7):e024410. PubMed ID: 35322667
[TBL] [Abstract][Full Text] [Related]
13. Human-induced pluripotent stem cells as models for rare cardiovascular diseases: from evidence-based medicine to precision medicine.
Pan Z; Ebert A; Liang P
Pflugers Arch; 2021 Jul; 473(7):1151-1165. PubMed ID: 33206225
[TBL] [Abstract][Full Text] [Related]
14. An induced pluripotent stem cell model of hypoplastic left heart syndrome (HLHS) reveals multiple expression and functional differences in HLHS-derived cardiac myocytes.
Jiang Y; Habibollah S; Tilgner K; Collin J; Barta T; Al-Aama JY; Tesarov L; Hussain R; Trafford AW; Kirkwood G; Sernagor E; Eleftheriou CG; Przyborski S; Stojković M; Lako M; Keavney B; Armstrong L
Stem Cells Transl Med; 2014 Apr; 3(4):416-23. PubMed ID: 24591732
[TBL] [Abstract][Full Text] [Related]
15. Contribution of two-pore K
Chai S; Wan X; Nassal DM; Liu H; Moravec CS; Ramirez-Navarro A; Deschênes I
Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1144-H1153. PubMed ID: 28341634
[TBL] [Abstract][Full Text] [Related]
16. Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Bezzerides VJ; Zhang D; Pu WT
Circ J; 2016 Dec; 81(1):12-21. PubMed ID: 27916777
[TBL] [Abstract][Full Text] [Related]
17. Noncoding RNAs and Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Cardiac Arrhythmic Brugada Syndrome.
Theisen B; Holtz A; Rajagopalan V
Cells; 2023 Oct; 12(19):. PubMed ID: 37830612
[TBL] [Abstract][Full Text] [Related]
18. Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells.
Wen JY; Wei CY; Shah K; Wong J; Wang C; Chen HS
Circ J; 2015; 79(7):1402-8. PubMed ID: 25971409
[TBL] [Abstract][Full Text] [Related]
19. HiPSC-derived cardiomyocyte to model Brugada syndrome: both asymptomatic and symptomatic mutation carriers reveal increased arrhythmogenicity.
Penttinen K; Prajapati C; Shah D; Rajan DK; Cherian RM; Swan H; Aalto-Setälä K
BMC Cardiovasc Disord; 2023 Apr; 23(1):208. PubMed ID: 37098502
[TBL] [Abstract][Full Text] [Related]
20. Comparing human iPSC-cardiomyocytes versus HEK293T cells unveils disease-causing effects of Brugada mutation A735V of Na
de la Roche J; Angsutararux P; Kempf H; Janan M; Bolesani E; Thiemann S; Wojciechowski D; Coffee M; Franke A; Schwanke K; Leffler A; Luanpitpong S; Issaragrisil S; Fischer M; Zweigerdt R
Sci Rep; 2019 Aug; 9(1):11173. PubMed ID: 31371804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
